Search

Home > New England Journal of Medicine Interviews > NEJM Interview: Dr. Walid Gellad on strategies for managing the cost of drugs receiving accelerated FDA approval.
Podcast: New England Journal of Medicine Interviews
Episode:

NEJM Interview: Dr. Walid Gellad on strategies for managing the cost of drugs receiving accelerated FDA approval.
Category: Religion & Spirituality
Duration: 00:09:56
Publish Date: 2017-05-24 10:01:00
Description:   Dr. Walid Gellad is an associate professor of medicine and health policy and codirector of the Center for Pharmaceutical Policy and Prescribing at the University of Pittsburgh. Stephen Morrissey, the interviewer, is the Managing Editor of the Journal. W.F. Gellad and A.S. Kesselheim. Accelerated Approval and Expensive Drugs - A Challenging Combination. N Engl J Med 2017;376:2001-4.  
Total Play: 0

Users also like

1K+ Episodes
医学講座 400+     50+
400+ Episodes
NEJM This We .. 90+     10+

Some more Podcasts by NEJM Group

400+ Episodes
NEJM This We .. 90+     10+
100+ Episodes
Clinical Con .. 10+     4
70+ Episodes
NEJM Residen ..    
900+ Episodes
NEJM Intervi ..